IPI on the Midway: Neuroscience community gathers to explore cell communication and antibody research
The Institute for Protein Innovation (IPI) brought its Antibodies Roadshow back for a second year…
IPI debuts Springer-Lu Postdoctoral Fellowship to support the next generation of protein scientists
The Institute for Protein Innovation (IPI), a nonprofit research institute dedicated to advancing protein science,…
Chang Yang grows with IPI — and goes beyond
When Chang Yang joined the Institute for Protein Innovation (IPI) in 2021, she was just…
Training the next generation in lab automation
Lab automation is becoming a game-changer in biomedical research, enabling scientists to work faster, get…
IPI scientists take on PEGSummit 2025
It’s that time of year in Boston when the flowers bloom, the trees bud and…
Machining antibodies at IPI
Very little these days escapes the reach of machine learning (ML) and, more broadly, artificial…
Axon Guidance: Explained
In the late 19th century, neuroscientist Santiago Ramón y Cajal peered through a microscope at…
IPI receives grant from Chan Zuckerberg Initiative to develop next-generation protein tools for neuroscience research
Funding supports creation and open distribution of critical research tools to accelerate neuroscience discoveries Boston,…
IPI targets neurexin with upcoming antibody suite
Synaptic function involves the interactions of hundreds, maybe thousands, of different proteins. A particular family,…
Epitope tag antibodies, plasmids and data transparency: A Q&A with Mike Walden
In 2024, the Institute for Protein Innovation (IPI) released a set of antibodies targeting nine…
Year in review: Looking back on 2024
It’s been a whirlwind year here at IPI, from antibody releases to workshops and lab…
Michael Walden bridges two worlds as IPI’s commercial director
Driving commercial development at a nonprofit institution is a challenge. The business models are complex…